
1. General Information
Elromo 50 mg Tablet is an oral prescription medicine containing Eltrombopag 50 mg. It belongs to the therapeutic class known as thrombopoietin receptor agonists (TPO-RAs).
Eltrombopag works by stimulating thrombopoietin receptors involved in platelet production in the bone marrow. It is prescribed for selected patients with low platelet counts associated with conditions such as chronic immune thrombocytopenia (ITP), severe aplastic anemia, and certain cases of chronic hepatitis C-associated thrombocytopenia.
2. Product Information
- Brand: Elromo 50 mg
- Active ingredient: Eltrombopag
- Strength: 50 mg
- Dosage form: Tablet
- Route: Oral
- Therapeutic class: Thrombopoietin receptor agonist
- Prescription status: Prescription medicine
- Manufacturer/Marketer: Zydus
- Origin: India
The 50 mg strength is one of the established oral strengths of eltrombopag products.
3. Uses of Elromo 50 mg
Elromo 50 mg may be prescribed for:
- Chronic immune thrombocytopenia (ITP): To increase platelet counts when previous treatments have not provided an adequate response.
- Severe aplastic anemia (SAA): In appropriate patients whose disease has not responded adequately to immunosuppressive treatment and who are unsuitable for stem-cell transplantation.
- Chronic hepatitis C-associated thrombocytopenia: In certain treatment settings where low platelet counts have limited interferon-based therapy.
The exact indication and treatment regimen depend on the patient's diagnosis and medical history.
4. Benefits of Elromo 50 mg
The main therapeutic benefit of Elromo 50 mg is its ability to increase platelet production.
Potential clinical benefits include:
- Helps raise platelet counts.
- May reduce the risk of bleeding associated with very low platelet levels.
- May help maintain platelet counts within a target range during treatment.
- Can support the management of chronic ITP and selected cases of severe aplastic anemia.
- May reduce the need for platelet transfusions in appropriate patients.
Eltrombopag has demonstrated greater platelet-count response than placebo in clinical studies of adults with ITP.
5. Side Effects of Elromo 50 mg
Like other prescription medicines, Elromo 50 mg can cause side effects. The severity and frequency can vary between patients.
Possible adverse effects include:
- Nausea
- Diarrhea
- Headache
- Dizziness
- Muscle or joint discomfort
- Fatigue
- Abdominal discomfort
- Abnormal liver enzyme levels
Important but less common complications can include liver problems and thromboembolic events (blood clots).
6. Common Side Effects
Some commonly reported side effects associated with eltrombopag include:
- Nausea
- Diarrhea
- Headache
- Fatigue
- Abdominal pain or discomfort
- Respiratory infections in some patient groups
- Abnormal liver-function test results
Patients should inform their healthcare professional if side effects are persistent, severe, or worsening.
7. How to Use Elromo 50 mg
Elromo 50 mg should be taken exactly as prescribed by a qualified healthcare professional.
General administration guidance includes:
- Take the tablet orally with water.
- Swallow the tablet whole; do not crush or chew it.
- It is generally taken on an empty stomach.
- Keep the timing consistent from day to day.
- Avoid taking it together with calcium-rich foods, mineral supplements or antacids containing polyvalent minerals because these can reduce eltrombopag absorption.
- If a dose is missed, follow the prescribing doctor's instructions rather than taking an extra dose.
The appropriate dose varies according to the underlying condition, age, platelet response, liver function and other clinical factors.
8. How Elromo 50 mg Works
Elromo 50 mg contains eltrombopag, which acts as a thrombopoietin receptor agonist.
Normally, thrombopoietin stimulates receptors in the bone marrow that regulate the production of platelets. Eltrombopag also stimulates these receptors, activating signals that encourage the development of megakaryocytes and subsequently increase platelet production.
As platelet production increases, the platelet count in the blood can rise, helping manage thrombocytopenia in appropriate patients.
9. Safety Advice
Elromo 50 mg should be used only under appropriate medical supervision.
Liver:
Eltrombopag can affect liver function. Patients may require liver-function monitoring during treatment, particularly when there is pre-existing liver disease.
Blood clots:
Increasing platelet counts excessively can increase the risk of thrombotic or thromboembolic complications. The medicine should therefore be used at the dose required to achieve the intended platelet response.
Drug and food interactions:
Calcium-rich foods, mineral supplements containing iron, calcium, magnesium, zinc and similar minerals, and certain antacids can interfere with absorption. Appropriate separation from these products is important.
Pregnancy and breastfeeding:
Patients who are pregnant, planning pregnancy or breastfeeding should discuss treatment with their healthcare professional before using eltrombopag.
Monitoring:
Regular blood counts and other laboratory tests may be required to monitor platelet response and safety.
Prescription use:
Elromo 50 mg should not be started, stopped or dose-adjusted without medical advice.
10. Frequently Asked Questions
What is Elromo 50 mg Tablet?
Elromo 50 mg Tablet is a prescription medicine containing eltrombopag 50 mg, used to increase platelet counts in selected patients with thrombocytopenia.
What is Elromo 50 mg used for?
It may be used for chronic immune thrombocytopenia, severe aplastic anemia and certain cases of hepatitis C-associated thrombocytopenia, depending on the patient's clinical situation.
Is Elromo 50 mg a steroid?
No. Elromo contains eltrombopag and belongs to the thrombopoietin receptor agonist class.
How does Elromo increase platelets?
Eltrombopag stimulates thrombopoietin receptors in the bone marrow, encouraging platelet production.
Can Elromo 50 mg be taken with food?
It is generally taken on an empty stomach. Calcium-rich foods and certain mineral-containing products can reduce absorption and should be appropriately separated from the dose.
Can I stop Elromo when my platelet count improves?
Do not stop or change the dose without consulting the prescribing doctor. Platelet counts can fall after treatment is stopped.
Does Elromo cure ITP?
Elromo helps manage low platelet counts; it does not necessarily cure the underlying immune disorder.
Does Elromo require blood tests?
Yes. Doctors generally monitor platelet counts and may monitor liver function and other parameters during treatment.
Can Elromo cause blood clots?
Excessively high platelet counts and eltrombopag treatment can be associated with thrombotic or thromboembolic complications, so monitoring is important.
Is Elromo 50 mg available as a tablet?
Yes. Elromo 50 mg is an oral tablet containing eltrombopag.
11. Substitute for Elromo 50 mg
Possible alternatives containing eltrombopag include other brands or generic versions of the same active ingredient. For example, Revolade is an established eltrombopag product, and Eltrombopag Accord is another authorised eltrombopag medicine in the EU.
However, a substitute should not be selected solely by brand name. The active ingredient, strength, formulation, indication and patient's clinical condition must be matched by a healthcare professional.
12. SEO & B2B Keywords
- Elromo 50 mg Tablet exporter from India
- Elromo 50 mg Eltrombopag supplier India
- Elromo 50 mg tablets pharmaceutical exporter
- Elromo 50 mg wholesale supplier India
- Eltrombopag 50 mg tablets exporter
- Eltrombopag 50 mg pharmaceutical supplier
- Elromo 50 mg tablets manufacturer supplier
- Elromo 50 mg tablets export from Nagpur
- Elromo 50 mg medicine exporter Nagpur India
- Eltrombopag tablets wholesale India
- Eltrombopag 50 mg B2B supplier
- Elromo 50 mg international pharmaceutical supplier
- Elromo 50 mg tablets for ITP treatment
- Eltrombopag 50 mg for low platelet count
- Elromo 50 mg tablets for thrombocytopenia
- Elromo 50 mg tablets supplier USA
- Elromo 50 mg tablets supplier UK
- Elromo 50 mg tablets supplier Australia
- Elromo 50 mg tablets supplier Singapore
- Elromo 50 mg tablets supplier Canada
- Elromo 50 mg tablets supplier South Korea
- Elromo 50 mg tablets supplier UAE
- Eltrombopag 50 mg export from India
- Prescription medicine exporter India
- Oncology and hematology medicine exporter India
- ITP medicine supplier from India
- Platelet stimulating medicine supplier India
- Eltrombopag tablets B2B export supplier
- Elromo 50 mg bulk pharmaceutical supplier
- Phoenix Exim Elromo 50 mg exporter
- Phoenix Exim Eltrombopag supplier Nagpur
- Trusted pharmaceutical exporter from India
- Eltrombopag 50 mg wholesale export supplier
- Elromo 50 mg international B2B medicine supplier
- Elromo 50 mg pharmaceutical export company
Keywords







